We describe 3 patients, 2 with inflammatory bowel dis- Sweet Syndrome Associated With Crohn’s Disease Developed After a Combo Therapy With Infliximab and Azathioprine: A Case Report Abstract
Sweet syndrome is a rare complication of azathioprine treatment with unelucidated clinical features
The diagnosis of azathioprine-induced Sweet syndrome was confirmed
Sweet's syndrome, also known as Acute Febrile Neutrophilic Dermatosis, is a rare inflammatory condition
Information about Sweet syndrome (SS)’s clinical course as a rare cutaneous
Acute febrile neutrophilic dermatosis also has the eponymous name, Sweet syndrome or
by the sudden onset of papules and nodules which are tender and reddish/purple
Azathioprine hypersensitivity can present occasionally within weeks of initial therapy as Sweet-like Syndrome
Sweet syndrome (acute febrile neutrophilic dermatosis) is a neutrophilic dermatosis characterized by the abrupt appearance of edematous and erythematous papules, plaques, or nodules on the skin
Azathioprine-induced Sweet's syndrome (SS) is rare and usually overlooked because it can mimic disease exacerbation and sepsis
Introduction: Azathioprine hypersensitivity can occasionally present as Sweet-like syndrome, a dose-independent side effect characterized by the unanticipated onset of macules, papules, and Azathioprine-induced Sweet's syndrome
Affiliation 1 Methods
The diagnosis of Sweet syndrome was established, and the temporal relationship between azathioprine administration and clinical presentation raised the suspicion for drug-induced Sweet syndrome
Sweet syndrome secondary to azathioprine therapy is rarely reported
They include: Painful bumps or small blisters filled with pus on the face, neck, arms, or legs
Azathioprine-induced Sweet's syndrome and azathioprine hypersensitivity reaction, a more severe and systemic reaction often involving neutrophilic dermatosis, are rare adverse effects
Azathioprine (AZA) is a commonly used immunosuppressive therapy that has been implicated in a number of cutaneous and systemic inflammatory reactions
2008 Dec;14(12):1757-8
and the histologic findings on skin biopsy, a component of the Sweet Syndrome was assumed
Azathioprine (AZA) is a medication used in the management and treatment of active rheumatoid arthritis (RA) and the prevention of kidney transplant rejection